Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial

BACKGROUND: Hyperbaric oxygen has been used as a therapy for patients experiencing chronic intestinal syndromes after pelvic radiotherapy for decades, yet the evidence to support the use of this therapy is based almost exclusively on non-randomised studies. We aimed to provide conclusive results for...

Descripción completa

Detalles Bibliográficos
Autores principales: Glover, Mark, Smerdon, Gary R, Andreyev, H Jervoise, Benton, Barbara E, Bothma, Pieter, Firth, Oliver, Gothard, Lone, Harrison, John, Ignatescu, Mihaela, Laden, Gerard, Martin, Sue, Maynard, Lauren, McCann, Des, Penny, Christine E L, Phillips, Spencer, Sharp, Grace, Yarnold, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737893/
https://www.ncbi.nlm.nih.gov/pubmed/26703894
http://dx.doi.org/10.1016/S1470-2045(15)00461-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737893/
https://www.ncbi.nlm.nih.gov/pubmed/26703894
http://dx.doi.org/10.1016/S1470-2045(15)00461-1

Ejemplares similares